Policy & Regulation
While no doubt welcome, yet another delay to the EU Deforestation Law and suggestion for another review next year could mean a “never-ending” regulatory exercise that creates uncertainty for manufacturers selling products containing or having been made using materials like palm oil, soya and wood.
A round up of the latest people moves in Europe: ANEFP names president; Pharma Deutschland makes board changes; Salus shakes up management.
UK consumer healthcare industry association, PAGB, suggests improvements that could help accelerate Rx-to-OTC switch in the country.
A new cohort of “techno-enthusiasts” who are highly susceptible to misinformation and inappropriate self-care decisions are undermining Italy's responsible self-medication model, finds a report by Italian self-care industry association, Assosalute, and independent researcher Censis.
Negative growth in global OTC market sales volume means that “as an industry, we're not doing good enough,” argues Opella’s Asia Pacific, Middle East and Africa (AMEA) head, Carol-Ann Stewart, in this exclusive feature interview.
In the second part of a special Self-Care Week episode of Over the Counter, HBW Insight speaks to PAGB CEO Michelle Riddalls about what the association is doing to promote self-care.
OMUFA reauthorization and directions for FDA to provide reports on monograph program and guidance on improving chances for OTC switch applications included in recent stopgap spending bill to end federal government shutdown.
“It’s not good enough just to provide products anymore, we need to create a service and a holistic approach to products,” argued Bayer Consumer Health's Northern Europe general manager, Mike Knowland, speaking at a recent panel event in the UK Parliament.
The studies reviewed by BMJ researchers failed to account for the fact that the association between in utero exposure to paracetamol and autism and ADHD in childhood “might be driven by familial genetic and environmental factors.”
But the Senate’s reduction would not be as much as the House of Representatives and President Trump proposed earlier this year, which is likely a win for the agency.
Scientific literature on potential link between prenatal acetaminophen exposure and neurological conditions “now includes FDA’s most recent epidemiological review” completed in May saying research results “insufficient to support a causal association.”
EllaOne manufacturer Perrigo tells HBW Insight that Community Pharmacy England's decision to offer free emergency contraception is "the right move for women" but also "makes pharmacy training and sex education more important than ever."
Norway's Medical Products Agency has rejected claims that misuse of OTC ibuprofen is linked to its availability for purchase in outlets other than pharmacies.
EU legislation aimed at controlling at source emerging pollutants such commonly used OTC analgesics like ibuprofen and diclofenac and “forever chemicals” like perfluoroalkyl and polyfluoroalkyl substances (PFAS) edges closer to adoption.
A recent public consultation by the European Parliament’s Committee on Public Health (SANT) shows dissatisfaction with how women’s specific health needs are being met in the EU.
With climate change increasing the prevalence of allergic rhinitis across the world, especially in children stuck in badly ventilated classrooms, experts in a Bayer-funded paper stress the need for further education of healthcare professionals and access to good OTC solutions.
The United for Self-Care Coalition publishes a manifesto that it hopes will accelerate the UN’s vision set out in a recent political declaration that aims to prevent and control non-communicable diseases and promote mental health and wellbeing.
In addition to Kenvue, complaint names as defendant J&J, which for decades marketed Tylenol oral analgesics before spinning Kenvue out in 2023. State asks court to order firms to pay $10,000 for each violation of state Deceptive Trade Practices-Consumer Protection Act.
BRS Analytical Services in St. Louis recalled more than 75,000 cases of redness and lubricating eye drops and committed “to permanently cease production of all drugs.”
The “Simple Reform” initiative would reverse a 2017 move to ensure FDA investigators were experts in the commodity they inspected or in clinical research regulations.